What is the current Price Target for the Akero Therapeutics Inc stock?

The average Akero Therapeutics Inc target price is $59.16. This is 9.27% higher than the current stock price. The highest price target is 111.40%, the lowest is 0.74%. 11 Analysts have issued a price target Akero Therapeutics Inc 2026 .

How high will the Akero Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Akero Therapeutics Inc stock will rise. The performance of stocks, including the Akero Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Akero Therapeutics Inc stock today?

The performance of Akero Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Akero Therapeutics Inc stock fall?

The decline in Akero Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Akero Therapeutics Inc Forecast, price target & analysts

$54.14

0.19% yesterday

Nasdaq, Nov 10, 10:00 pm CET

ISIN

US00973Y1082

Symbol

AKRO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Akero Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Akero Therapeutics Inc Classifications & Recommendation:

Buy

56%

Hold

44%

Akero Therapeutics Inc Price Target

Target Price	$59.16
Price	$54.14
Potential	9.27% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Akero Therapeutics Inc 2026 . The average Akero Therapeutics Inc target price is $59.16. This is 9.27% register free of charge higher than the current stock price. The highest price target is $114.45 111.40% register free of charge , the lowest is $54.54 0.74% register free of charge .
	A rating was issued by 16 analysts: 9 Analysts recommend Akero Therapeutics Inc to buy, 7 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Akero Therapeutics Inc stock has an average upside potential 2026 of 9.27% register free of charge . Most analysts recommend the Akero Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.75	-3.72
	29.76%	0.80%
P/E		negative

11 Analysts have issued a Akero Therapeutics Inc forecast for earnings per share. The average Akero Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.75	29.76%
2025	$-3.72 0.80% Unlock
2026	$-4.20 12.90% Unlock
2027	$-4.58 9.05% Unlock
2028	$-1.95 57.42% Unlock
2029	$2.12 208.72% Unlock
2030	$9.19 333.49% Unlock
2031	$17.89 94.67% Unlock
2032	$8.68 51.48% Unlock

Current	-15.57	64.26%
2025	-14.54 6.64% Unlock
2026	-12.86 11.55% Unlock
2027	-11.79 8.32% Unlock
2028	-27.67 134.69% Unlock
2029	25.47 192.05% Unlock
2030	5.88 76.91% Unlock
2031	3.02 48.64% Unlock
2032	6.23 106.29% Unlock

Akero Therapeutics Inc...

Current Akero Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wolfe Research	Locked ➜ Locked	Locked	Oct 10 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 10 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Oct 09 2025
Jefferies	Locked ➜ Locked	Locked	Oct 09 2025
TD Cowen	Locked ➜ Locked	Locked	Aug 04 2025
B of A Securities	Locked ➜ Locked	Locked	May 27 2025
Citigroup	Locked ➜ Locked	Locked	May 13 2025

Analyst Rating	Date
Locked Wolfe Research: Locked ➜ Locked	Oct 10 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 10 2025
Locked Canaccord Genuity: Locked ➜ Locked	Oct 09 2025
Locked Jefferies: Locked ➜ Locked	Oct 09 2025
Locked TD Cowen: Locked ➜ Locked	Aug 04 2025
Locked B of A Securities: Locked ➜ Locked	May 27 2025
Locked Citigroup: Locked ➜ Locked	May 13 2025

Discover more stocks with a high price target

Novo Nordisk 58.35%

TUI 56.79%

Adidas 52.97%

Deutsche Telekom 45.22%

Meta Platforms (Facebook) 41.27%

Adyen 38.23%

BYD 33.57%

BioNTech SE - ADR 32.51%

Coinbase Global, Inc. 29.61%

Infineon 28.48%

Microsoft 27.00%

Netflix 26.58%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now